Document is current
Any future updates will be listed below
-
Authors
Nagano, China
Sako, Mayumi
Kamei, Koichi
Ishikura, Kenji
Nakamura, Hidefumi
Nakanishi, Koichi
Omori, Takashi
Nozu, Kandai
Iijima, Kazumoto https://orcid.org/0000-0003-0378-8174
-
Funding
Funding for this research was provided by:
Zenyaku Kogyo Co., Ltd. (ANZ2170030)
- License Information
-
More Information
Article History
Received: 17 November 2018
Accepted: 19 July 2019
First Online: 2 August 2019
Ethics approval and consent to participate
: This study is being performed in accordance with the Declaration of Helsinki. The study protocol is currently being reviewed by Tokyo Metropolitan Children’s Hospital Institutional Review Board (IRB), but has already been approved by the IRB of each of 11 other hospitals. The IRB names and a reference number are as follows:
: Not applicable.
: Mayumi Sako received a consulting fee from Zenyaku Kogyo Co. Ltd. Kenji Ishikura received a grant from Chugai Pharmaceutical Co., Ltd. and Novartis Pharma K.K., and a lecture fee from Zenyaku Kogyo Co. Ltd. and Novartis Pharma K.K. Koichi Kamei has received lecture fees from Chugai Pharmaceutical Co., Ltd. Koichi Nakanishi received lecture fees from Chugai Pharmaceutical Co., Ltd. and Novartis Pharma K.K. Kandai Nozu received lecture fees from Chugai Pharmaceutical Co., Ltd. Kazumoto Iijima received a grant from Zenyaku Kogyo Co. Ltd. and lecture and/or consulting fees from Chugai Pharmaceutical Co., Ltd., Zenyaku Kogyo Co. Ltd., Takeda Pharmaceutical Co., Ltd., Novartis Pharma K.K. and Kyowa Hakko Kirin Co. Ltd.
